Literature DB >> 16107856

High blood pressure is inversely related with the presence and extent of coronary collaterals.

J Koerselman1, P P Th de Jaegere, M C Verhaar, Y van der Graaf, D E Grobbee.   

Abstract

Patients with hypertension have an increased case fatality during acute myocardial infarction (MI). Coronary collateral (CC) circulation has been proposed to reduce the risk of death during acute ischaemia. We determined whether and to which degree high blood pressure (BP) affects the presence and extent of CC circulation. A cross-sectional study in 237 patients (84% males), admitted for elective coronary angioplasty between January 1998 and July 2002, was conducted. Collaterals were graded with Rentrop's classification (grade 0-3). CC presence was defined as Rentrop-grade > or =1. BP was measured twice with an inflatable cuff manometer in seated position. Pulse pressure was calculated by systolic blood pressure (SBP)-diastolic blood pressure (DBP). Mean arterial pressure was calculated by DBP+1/3 x (SBP-DBP). Systolic hypertension was defined by a reading > or =140 mmHg. We used logistic regression with adjustment for putative confounders. SBP (odds ratio (OR) 0.86 per 10 mmHg; 95% confidence interval (CI) 0.73-1.00), DBP (OR 0.67 per 10 mmHg; 95% CI 0.49-0.93), mean arterial pressure (OR 0.73 per 10 mmHg; 95% CI 0.56-0.94), systolic hypertension (OR 0.49; 95% CI 0.26-0.94), and antihypertensive treatment (OR 0.53; 95% CI 0.27-1.02), each were inversely associated with the presence of CCs. Also, among patients with CCs, there was a graded, significant inverse relation between levels of SBP, levels of pulse pressure, and collateral extent. There is an inverse relationship between BP and the presence and extent of CC circulation in patients with ischaemic heart disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16107856     DOI: 10.1038/sj.jhh.1001917

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  7 in total

Review 1.  Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation.

Authors:  Jörn Tongers; Jerome G Roncalli; Douglas W Losordo
Journal:  Microvasc Res       Date:  2010-02-06       Impact factor: 3.514

2.  Cardiovascular risk factors cause premature rarefaction of the collateral circulation and greater ischemic tissue injury.

Authors:  Scott M Moore; Hua Zhang; Nobuyo Maeda; Claire M Doerschuk; James E Faber
Journal:  Angiogenesis       Date:  2015-04-11       Impact factor: 9.596

Review 3.  With a Little Help From My Friends: the Role of the Renal Collateral Circulation in Atherosclerotic Renovascular Disease.

Authors:  Jakob Nyvad; Amir Lerman; Lilach O Lerman
Journal:  Hypertension       Date:  2022-02-09       Impact factor: 10.190

4.  Predictor of poor coronary collaterals in chronic kidney disease population with significant coronary artery disease.

Authors:  Po-Chao Hsu; Suh-Hang Juo; Ho-Ming Su; Szu-Chia Chen; Wei-chung Tsai; Wen-Ter Lai; Sheng-Hsiung Sheu; Tsung-Hsien Lin
Journal:  BMC Nephrol       Date:  2012-08-30       Impact factor: 2.388

Review 5.  Reduced coronary collateralization in type 2 diabetic patients with chronic total occlusion.

Authors:  Ying Shen; Feng Hua Ding; Yang Dai; Xiao Qun Wang; Rui Yan Zhang; Lin Lu; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2018-02-08       Impact factor: 9.951

6.  Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: association with hyperglycaemia, insulin-resistance, adiponectin and plasminogen activator inhibitor-1.

Authors:  Frédéric Mouquet; François Cuilleret; Sophie Susen; Karine Sautière; Philippe Marboeuf; Pierre Vladimir Ennezat; Eugène McFadden; Pascal Pigny; Florence Richard; Bernadette Hennache; Marie Christine Vantyghem; Michel Bertrand; Jean Dallongeville; Brigitte Jude; Eric Van Belle
Journal:  Eur Heart J       Date:  2009-01-22       Impact factor: 29.983

Review 7.  Determinants of human coronary collaterals.

Authors:  Stefano F de Marchi
Journal:  Curr Cardiol Rev       Date:  2014-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.